Dyax Corp.

Dyax Corp.

Sector: Commercial Physical And Biological Research Region: MA, United States

: | Nasdaq: DYAX

Similar to: Exelixis, Inc., Pierrel SpA, Medivir AB

Dyax Corp. is a biopharmaceutical company, which discovers, develops and commercializes biopharmaceuticals for unmet medical needs. The company utilizes its proprietary drug discovery technology to identify antibody, small protein and peptide compounds for clinical development. It also develops angioedema portfolio for the prophylactic treatment of hereditary angioedema and a diagnostic test to identify plasma kallikrein-mediated disorders. Dyax was founded in 1995 and is headquartered in Burlington, MA.

News & Analysis

You may also be interested in: